In 2024, the Company’s impact was reflected in its products, planet-first practices, and partnerships — including the launch of the Jane Goodall Collection, which supports crucial conservation efforts ...
Denifanstat Phase 3 MASH program initiated in Q4 2024; patient screening expected to start in 1H 2025Denifanstat received Breakthrough Therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback